Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation

Hum Reprod. 2004 Nov;19(11):2545-9. doi: 10.1093/humrep/deh452. Epub 2004 Oct 7.

Abstract

Background: The purpose of this study was to evaluate the use of the modified natural cycle (MNC) for IVF in poor responders as a last resort prior to oocyte donation.

Methods: Thirty-two patients with a regular menstrual cycle, FSH levels on day 3 of the cycle >12 IU/l and one or more failed IVF cycles with five or fewer cumulus-oocyte complexes (COCs) retrieved were included in this prospective study. Recombinant FSH 100 IU and GnRH antagonist 0.25 mg/day were started concomitantly when a follicle with a mean diameter of 14 mm was present at ultrasound. HCG 10 000 IU was administered as soon as the mean follicular diameter was > or =16 mm.

Results: Twenty-five out of 78 cycles performed (32.1%) did not result in oocyte retrieval. In nine out of 53 cycles (16.9%) in which oocyte retrieval was performed, no COCs were retrieved. Following fertilization, embryo transfer was performed in 19 out of 44 cycles in which COCs were retrieved (43.2%). No ongoing pregnancy was achieved in 78 MNCs (0.0%; 95% confidence interval 0.0-4.7).

Conclusions: MNC does not offer a realistic chance of parenthood in patients with high levels of FSH on day 3 of the cycle and previous poor response to ovarian stimulation, when offered as a last resort prior to oocyte donation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chorionic Gonadotropin / therapeutic use
  • Embryo Transfer
  • Female
  • Fertilization in Vitro / methods*
  • Follicle Stimulating Hormone / blood*
  • Follicle Stimulating Hormone / pharmacology
  • Follicular Phase / drug effects
  • Follicular Phase / physiology
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Humans
  • Infertility, Female / drug therapy
  • Infertility, Female / therapy*
  • Oocyte Donation
  • Oocytes / drug effects
  • Oocytes / physiology*
  • Ovarian Follicle / diagnostic imaging
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / physiology
  • Ovulation Induction / methods*
  • Pregnancy
  • Treatment Failure
  • Ultrasonography

Substances

  • Chorionic Gonadotropin
  • Gonadotropin-Releasing Hormone
  • Follicle Stimulating Hormone